세계의 치매 관리 제품 시장 예측(-2032년) : 제품별, 유통 채널별, 최종 사용자별, 지역별 분석

According to Stratistics MRC, the Global Dementia Care Products Market is accounted for $27.07 million in 2025 and is expected to reach $47.61 million by 2032 growing at a CAGR of 8.4% during the forecast period. Dementia care products are specialized tools, devices, and aids designed to support individuals living with dementia and improve their quality of life. These products promote safety, independence, comfort, and cognitive support, both at home and in care settings. Common examples include memory aids, orientation clocks, adaptive clothing, GPS trackers, sensory therapy tools, and easy-to-use household items. They help reduce confusion, prevent wandering, manage agitation, and assist with daily living activities. Dementia care products also support caregivers by making care tasks easier and more effective, ultimately enhancing the overall well-being and dignity of those affected by cognitive decline.

According to the World Health Organization, approximately 55 million people worldwide will be living with dementia in 2023, with projections indicating this number will rise to 57 million by 2024.

Market Dynamics:

Driver:

Rising Global Dementia Prevalence

The rising global prevalence of dementia is driving significant growth in the dementia care products market. As more individuals and families face the challenges of memory loss and cognitive decline, demand increases for innovative, effective solutions that enhance quality of life and ease caregiving. This surge fuels research, product development, and technological advancements in assistive devices, safety tools, and daily living aids. Consequently, the market experiences a positive, forward-driving momentum, attracting investments and fostering global awareness around dementia care needs.

Restraint:

High Costs of Specialized Products

High costs of specialized dementia care products create significant barriers for many families, limiting access to essential tools and technologies. This financial burden reduces market demand, slowing innovation and product development. Additionally, high prices can widen health disparities, as lower-income individuals struggle to afford quality care solutions. Consequently, the market growth is hindered, and overall dementia care quality may decline due to restricted availability and adoption of advanced, specialized products.

Opportunity:

Technological Advancements in Care Products

Technological advancements in care products are absolutely transforming the dementia care products market by enhancing patient safety, improving caregiver efficiency, and enabling personalized care. Innovations such as wearable health monitors, GPS tracking devices, and AI-powered cognitive aids support early detection and better management of symptoms. These technologies also reduce caregiver burden and increase independence for individuals with dementia. As a result, demand for smart, tech-integrated solutions is driving market growth and encouraging further innovation in dementia care.

Threat:

Regulatory Challenges

Regulatory challenges significantly hinder the dementia care products market by causing delays in product approvals and increasing development costs. Strict compliance requirements create barriers for innovation, limiting the introduction of advanced care solutions. These hurdles also discourage investment and slow market growth, restricting access to effective products for patients. Additionally, varying regulations across regions complicate global distribution, further impeding timely availability and adoption of essential dementia care technologies.

Covid-19 Impact

The Covid-19 pandemic significantly impacted the dementia care products market by disrupting supply chains and limiting patient access to essential care items. Lockdowns and healthcare system strains led to reduce in-person support, increasing demand for home-based care solutions. However, heightened awareness of vulnerable populations, like those with dementia, drove innovation and adoption of remote monitoring and assistive technologies, ultimately reshaping care delivery and accelerating market growth post-pandemic.

The cognitive training tools segment is expected to be the largest during the forecast period

The cognitive training tools segment is expected to account for the largest market share during the forecast period as it offers non-invasive solutions that enhance cognitive function and slow disease progression. These tools support memory, attention, and problem-solving skills, complementing medical treatments and promoting independence. Increased adoption in home and institutional settings reflects growing recognition of non-pharmacological interventions. With rising dementia prevalence, the demand for innovative, evidence-based cognitive training solutions is boosting market growth and shaping a more holistic approach to dementia care.

The hospitals segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the hospitals segment is predicted to witness the highest growth rate, because of demand for advanced care solutions. Hospitals serve as key centers for diagnosis, treatment, and long-term care, thereby fostering adoption of innovative products such as cognitive aids, monitoring devices, and personal care tools. Their emphasis on patient safety, standardized care, and caregiver support further boosts market growth. Additionally, hospital-based research initiatives and collaborations accelerate product development, enhancing overall dementia care quality and accessibility.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising awareness, growing elderly populations, and improved healthcare infrastructure. Innovations in assistive technologies and supportive government initiatives are enhancing patient care and independence. Increasing investments by regional players and collaborations with global firms are accelerating product availability and affordability. These developments are not only improving quality of life for dementia patients but also creating significant economic and employment opportunities across the region.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to increased healthcare investment. Advancements in assistive technologies and home-based care solutions are boosting demand, enabling better quality of life for dementia patients. Government initiatives and strong support from healthcare providers further accelerate market growth. The region's robust infrastructure and innovation ecosystem also foster the development and adoption of effective dementia care products, propelling sustained market expansion.

Key players in the market

Some of the key players profiled in the Dementia Care Products Market include Eli Lilly and Company, Biogen Inc., Johnson & Johnson, Philips Healthcare, GE Healthcare, Medline Industries, Inc., Cardinal Health, Inc., AbbVie Inc., Roche Holding AG, AstraZeneca PLC, Sanofi S.A., Merck & Co., Inc., Amgen Inc., Pfizer Inc., Lundbeck A/S, GSK plc, Novartis AG, Teva Pharmaceutical Industries Ltd., Beurer GmbH and Doro AB.

Key Developments:

In April 2025, GE HealthCare and FPT Corporation have expanded their strategic partnership to accelerate AI-driven healthcare innovation. This collaboration includes the establishment of an FPT Competency Center in Vietnam, aimed at enhancing product strategy, development, and customer onboarding within GE HealthCare's digital ecosystem.

In March 2025, NVIDIA and GE HealthCare have announced a collaboration to advance autonomous diagnostic imaging, focusing on developing AI-driven X-ray and ultrasound technologies. This partnership aims to address the global shortage of radiology professionals and improve access to medical imaging services.

In January 2025, Sutter Health and GE HealthCare have entered into a seven-year strategic partnership, known as the "Care Alliance," aimed at enhancing diagnostic imaging services across California.

Products Covered:

• Memory Exercise & Activity Products
• Medication Management Products
• Daily Reminder Products
• Bathroom Safety Products
• Dining Aids
• Therapeutic Devices
• Cognitive Training Tools
• Mobility Assistance Products
• Personal Safety Devices
• Communication Aids
• Incontinence Products
• Other Products

Distribution Channels Covered:

• Online Retail
• Pharmacies
• Specialty Stores
• Supermarkets/Hypermarkets
• Direct Sales

End Users Covered:

• Home Care Settings
• Long-term Care Centers
• Hospitals
• Assisted Living Facilities
• Nursing Homes
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Dementia Care Products Market, By Product

• 5.1 Introduction
• 5.2 Memory Exercise & Activity Products
• 5.3 Medication Management Products
• 5.4 Daily Reminder Products
• 5.5 Bathroom Safety Products
• 5.6 Dining Aids
• 5.7 Therapeutic Devices
• 5.8 Cognitive Training Tools
• 5.9 Mobility Assistance Products
• 5.10 Personal Safety Devices
• 5.11 Communication Aids
• 5.12 Incontinence Products
• 5.13 Other Products

6 Global Dementia Care Products Market, By Distribution Channel

• 6.1 Introduction
• 6.2 Online Retail
• 6.3 Pharmacies
• 6.4 Specialty Stores
• 6.5 Supermarkets/Hypermarkets
• 6.6 Direct Sales

7 Global Dementia Care Products Market, By End User

• 7.1 Introduction
• 7.2 Home Care Settings
• 7.3 Long-term Care Centers
• 7.4 Hospitals
• 7.5 Assisted Living Facilities
• 7.6 Nursing Homes
• 7.7 Other End Users

8 Global Dementia Care Products Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 Eli Lilly and Company
• 10.2 Biogen Inc.
• 10.3 Johnson & Johnson
• 10.4 Philips Healthcare
• 10.5 GE Healthcare
• 10.6 Medline Industries, Inc.
• 10.7 Cardinal Health, Inc.
• 10.8 AbbVie Inc.
• 10.9 Roche Holding AG
• 10.10 AstraZeneca PLC
• 10.11 Sanofi S.A.
• 10.12 Merck & Co., Inc.
• 10.13 Amgen Inc.
• 10.14 Pfizer Inc.
• 10.15 Lundbeck A/S
• 10.16 GSK plc
• 10.17 Novartis AG
• 10.18 Teva Pharmaceutical Industries Ltd.
• 10.19 Beurer GmbH
• 10.20 Doro AB